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Brussels, Belgium
In 1924, Willem Einthoven received the Nobel Prize for
physiology or medicine “for his discovery of the mecha-
nism of the electrocardiogram.” His colleague Sir
Thomas Lewis, regarded by many as another father of
clinical electrocardiography, was born in 1881, 21 years
after Einthoven, and it is said that Lewis could not
understand not being awarded the Nobel Prize together
with Einthoven, or even alone. Such can be the greatness
and the glory of one person, and so inane can be the stories
of others. The reality is that thanks to electrocardiography,
both physicians made superb contributions to what would
later become the medical specialty of cardiology. Cardiology
is unthinkable without electrocardiography, and these 2
men deserve a great deal of scientific respect, considering
that 110 years later after its development, electrocardiogra-
phy still contributes to our medical knowledge.
See page 2290
In this issue of the Journal, Chevallier et al. (1) bring us
new scientific information derived from electrocardio-
graphic (ECG) analysis. They compared the ECG findings
of patients with incomplete right bundle branch block with
those of patients with Brugada syndrome presenting with
spontaneous type 2 or 3 ECG patterns that changed into a
classic type 1 (coved) Brugada ECG pattern after pharma-
cologic challenge. The background for this study is clear:
patients with incomplete right bundle branch block may be
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companies.erroneously diagnosed as possibly having Brugada syn-
drome, and many patients do have incomplete right bundle
branch block. However, there are many ECG patterns that
are suspicious for Brugada syndrome, but in reality, they
reveal only innocent incomplete right bundle branch block.
Furthermore, types 2 and 3 of Brugada syndrome do
resemble incomplete right bundle branch block.
Are there ECG markers that can differentiate between
innocent incomplete right bundle branch block and a
potentially threatening Brugada type 2 or 3 ECG pattern?
the Chevallier et al. (1) study shows that there are significant
differences in the configuration of the r=-wave in leads V1
and V2 between incomplete right bundle branch block and
type 2 or 3 Brugada syndrome pattern. Measuring 2
ngles,  and , in leads V1 and V2, Chevallier et al. (1)
how that a reasonably good distinction can be made
etween incomplete right bundle branch block and a type 2
r 3 Brugada ECG pattern that will change into a type 1
CG pattern after drug challenge. This is very important
nd clinically useful information. In simple terms, the
=-wave in incomplete right bundle branch block is taller
nd narrower than the r=-wave in patients with Brugada
yndrome and type 2 or 3 ECG patterns.
Chevallier et al. (1) measured 2 angles to make the distinc-
ion: the  and  angles. The  angle was less accurate than the
 angle in terms of positive and negative predictive values.
owever, the  angle was not 100% sensitive and specific. This
is not a surprise when one correlates these data with present
speculation on the potential pathophysiologic mechanisms
involved in Brugada syndrome.
What do the  and  angles of Chevallier et al. (1)
easure? The  angle clearly relates to repolarization. An
ncipient ST-segment elevation of Brugada syndrome sim-
lating incomplete right bundle branch block results in an 
angle that is wider and falls more slowly than with incom-
plete right bundle branch block (their Fig. 1B, bottom
middle). The  angle is not influenced by the duration of
he QRS complex (depolarization). In contrast, their 
angle is related to both depolarization and repolarization: a
wider QRS complex (slow conduction) and abnormal repo-
larization both contribute to a wider  angle (their Fig. 1B,
bottom middle). Why then is the  angle more sensitive and
specific than the  angle but neither 100% sensitive nor
100% specific? It is because the ECG pattern is just the
phenotype of the different possible electrophysiologic mech-
anisms underlying Brugada syndrome.
The pathophysiologic mechanisms of Brugada syndrome.
There are at present 3 different hypotheses regarding the
pathophysiologic mechanisms of Brugada syndrome. For
the sake of simplicity (and because of the many scientific
contributors), I will refer to them as the Amsterdam, New
York, and Buenos Aires hypotheses.
The Amsterdam hypothesis was initially based on obser-
vations of a patient of mine who required cardiac transplan-
tation because of physically and psychologically intolerable
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his implantable cardioverter-defibrillator. Slow conduction
of the electrical impulse in the right ventricular outflow tract
(RVOT) was present and was shown to be responsible for
the initiation of ventricular fibrillation (2). This masterpiece
of scientific research by Colonel et al. (2) should be
obligatory reading in the curriculum of any cardiologist in
training. The study is comparable only with a previous
masterpiece of research by Durrer et al. (3), which in 1967
and also in Amsterdam mapped in a Langerdoff preparation
the total electrical activation of the normal human heart,
launching what would become the basis of modern cardiac
electrophysiology.
The New York hypothesis is based on experimental
models. Instead of slow conduction, the researchers in Utica
proposed that gradients in repolarization between RVOT
epicardium and endocardium result in the electrical hetero-
geneity that results in re-entry, based not on slow conduc-
tion (as in the Amsterdam hypothesis) but on phase 2
reentry (4). A mismatch in repolarization characteristics of
adjacent cardiac cells or regions (phase 2 or phase 3
re-entry) was proposed as a possible mechanism of arrhyth-
mias by my group as early as 1985. Although this was
initially seen as an unrealistic hypothesis, multiple later
studies proved it (5).
The Buenos Aires hypothesis is a fascinating one (6). It
combines the 2 aforementioned mechanisms (slow conduc-
tion and abnormal repolarization) on the basis of the
hypothesis that abnormal expression of cardiac neural crest
cells leads to abnormal depolarization and repolarization of
the RVOT (the “Achilles heel” of the heart, as the investi-
gators called it). According to this hypothesis, abnormal
expression of the cardiac neural crest cells would lead to
abnormal connexin expression, particularly connexin 43,
thereby creating the depolarization delay and heterogeneity
in repolarization necessary to induce the Brugada ECG
phenotype.
Are there any correlates for these 3 hypotheses? Indeed
there are.
In agreement with the Amsterdam hypothesis, we know
that the ECG pattern in Brugada syndrome shows not only
ST-segment elevation (on the basis of conduction delay
according to this hypothesis) but also true conduction delay,
as shown by PR prolongation and right bundle branch block
with a wide QRS complex. These findings fit with the
mutations in the sodium channel gene SCN5A frequently
found in these patients. However, mutations in the SCN5A
gene account for no more than 25% to 30% of patients with
Brugada syndrome.
In agreement with the New York hypothesis, we do
observe patients with Brugada syndrome with only repolar-
ization abnormalities and no conduction defects. These
patients fit much better with the individuals in whom
mutations are found in potassium or calcium channels. iThese represent a minority (1 in 1,000) of patients with
Brugada syndrome.
What about the Buenos Aires hypothesis? Why should
cardiac neural crest cells behave abnormally and in such a
specific area of the heart (the RVOT)? Does this hypothesis
explain the remaining 70% of patients with Brugada syn-
drome in whom mutations in the germinal-derived deoxy-
ribonucleic acid are not found? Do these patients carry
mutations in the mitochondrial deoxyribonucleic acid or
have somatic (nongerminal) cell-specific mutations? So-
matic mutations have already been shown to be involved in
RVOT ventricular tachycardia (6). As proposed by the
Buenos Aires hypothesis, specific development abnormali-
ties in the RVOT could also underlie not only Brugada
syndrome but also other “idiopathic” arrhythmias from and
around the RVOT area.
Chevallier et al. (1) bring us 1 major step further in the
potential genotype-phenotype correlations in Brugada syn-
drome. From a practical point of view, an ECG pattern with
incomplete right bundle branch block with a broad r=-wave
should arouse suspicion of the possibility of an underlying
channelopathy. If the  angle is 58° or more, a combined
epolarization and repolarization abnormality should be
uspected, probably related to a mutation in the cardiac
odium channel gene or to somatic mutations of the cardiac
eural crest cells. When Brugada syndrome is suspected,
onfirmation or exclusion by means of a pharmacologic
hallenge should be done.
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